Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article

 

When Will Biosimilars Impact The U.S. Market?

BioPharm Executive: 5 Reasons To Hate Biotech

Sanofi Ousts CEO After Clash Over Strategy

The 14 Best-Performing CEOs In Biotech

Under Immense Pressure, Amgen Outlines Strategy

3 Daily Servings Of Milk Linked To Higher Mortality In Women, Uppsala Universitet Study

Novo Nordisk A/S To Hire 90 In New Hampshire

Abbott Laboratories Pays $250 Million For Menlo Park Startup Topera

Is Violent Crime In Some People's Genes? Karolinska Institute Study

Cowen: Amgen???s Plans Are ???Music To Our Ears"

Don???t Bet On Stinginess To Keep Stress Low, Queensland University of Technology Study

Johnson & Johnson Launches Shanghai R&D Hub And Announces New Alliances

Tea And Citrus Products Could Lower Ovarian Cancer Risk, New University of East Anglia Research Finds

Breathe Easier: Get Your Vitamin D, Tel Aviv University Study

Does Having Children Make Us Any Happier? Study

Xencor Regains All Rights From Amgen To Rare AutoImmune Disease Drug, Dumps Arthritis Hopes

Pfizer Wins FDA Accelerated Approval For Meningitis Vaccine

MA BioPharma Aileron Therapeutics Locks In A Total Of $48 Million

Swiss Test GlaxoSmithKline Ebola Vaccine In Healthy Volunteers Going To Africa

Mushroom Extract, AHCC, Helpful In Treating HPV, University of Texas Health Science Center Research Shows

New Tax Rules Won???t Deter Pfizer From Bidding U.S. Goodbye: CEO

Whites Of Their Eyes: Infants Respond To Social Cues From Sclera, University of Virginia Study

Eli Lilly, Boehringer Ingelheim Corporation Revise Terms Of Diabetes Drugs Alliance

DATATRAK International, Inc. Bringing 85 New Jobs To Chicago

Ampio Pharmaceuticals, Inc. Could Have A Blockbuster Fourth Quarter, Says Citi

Cara Therapeutics, Inc. Touts Positive Data From New Opiod Pain Drug Trial

FDA Staff Recommends Limited Use Of Daiichi Sankyo, Inc.'s Blood Thinner Edoxaban

Ebola Epidemic Unlikely But Not Impossible, Says Immunovaccine Inc. CEO

Xcovery Raises $20 Million Through Equity Investment From China's

The Leukemia & Lymphoma Society Awards $15.6 Million To Help Advance Research From Lab To Clinic

Cesca Therapeutics Hunts For A New CEO

Laboratory And Health Technology Co., Medytox Solutions, Inc., Names Seamus Lagan New CEO

Amgen Now Expects Job Cuts To Exceed 2,900

Sanofi CEO Wrote To Board Asking To Keep His Job

Amgen Tells Analysts It Will Improve Margins 15% By Axing 4,000 Jobs

Novartis AG Expects New Heart Failure Drug As "Multi-Blockbuster"

Amgen's Exit: Where Will All Those Scientists Go?

Bristol-Myers Squibb Company Forges $475 Million Pact For Rights To f-Star's Cancer Drug

Receptos Soars As Bowel Disorder Drug Meets Phase 2 Goals

Sanofi Mulls Firing CEO

Sleeping With More Women Reduces Prostate Cancer Risk, University Of Montreal Study

Ebola???s Evolutionary Roots More Ancient Than Previously Thought, University at Buffalo Study

Amgen, Ono Pharmaceutical Company, Ltd., Sanofi Team Up With Academia On Proteins Project

Judge Slashes $9 Billion Award Vs Eli Lilly, Takeda Pharmaceutical Co. Ltd. In Actos Lawsuit By 99 Percent

Luye Pharma Pays $390 Million For Remaining 42% Of Beijing Jialin Pharma

Cerulean Pharma Inc. CEO Steps Down

Paragon Bioservices Grabs $13 Million

ImevaX Secures EUR 7.5 Million In Series A Financing To Develop Highly Specific Vaccine Against Helicobacter Pylori Infections

Valeant: We Will Bump Allergan Inc. Offer To $200 A Share

Merck & Co. Execs ???Downplaying??? Gilead Sciences, Inc.'s Harvoni Competitor, Says Analyst

Bio Venture Specialists Banks $235 Million Life Sciences Fund

AstraZeneca PLC May Walk Away From Antibiotics R&D

Novartis AG Sells Flu Vaccine Business For $275 Million To CSL Limited

Slowing The Biological Clock, Tel Aviv University Study

Synthetic Genomics, Inc. Appoints MBA As Chief Executive Officer

TxCell Achieves Positive Results For Col-Treg In A Model Of Autoimmune Uveitis

Manly Men Are Not Always the Best Choice For Partners, Study

Diet Soda Vs. Regular Soda: Is One Worse For You Than The Other?

Gut Bacteria Byproduct Impacts Heart Failure, Cleveland Clinic Research Shows

Ebola Clinical Trials: Big Name Players In The Ebola Race

First Atlas Of Body Clock Shows How Timing Affects Medication, University of Pennsylvania Study

Cocoa May Reverse Age-Related Memory Decline, Study

Mental Health Disorders Double Heart Disease, Stroke Risk, Study

Amgen Lays Off 274 Employees As Part Of Its Exit From Washington State

Is Sarepta Therapeutics Short Of Cash?

High Drug Prices Could Increase Industry Innovation

For A New Grad Interested In A Drug R&D Job, Is Biotech Better Than Big Pharma?

Citi: Sarepta Therapeutics Will See Competition, Concern Over FDA Delay

Sarepta Therapeutics Tanks As FDA Seeks Further Data On Eteplirsen; Stock Down 32.47% At Market Close (Oct. 27, 2014)

Bay Area's Coherus Biosciences Sets Terms For $85 Million IPO

Pain Therapeutics Tanks As Pfizer Walks Away From Remoxy® Deal

MA Startup Syros Pharmaceuticals Banks $53 Million Series B

Zogenix, Inc. Snags U.K.-Based Brabant Pharma In $35 Million Cash-Stock Deal

pSivida Corp Pockets $25 Million Milestone Payment

CTI BioPharma Grabs Exclusive Worldwide Rights To Tosedostat

Alchemia Shares Plummet On Failed Colorectal Cancer Trial

Akebia Therapeutics, Inc.'s Lead Drug AKB-6548 Succeeds In Mid-Stage Trial

Novo Nordisk A/S Receives U.S. Subpoena Related To Danish Factory

Merck & Co. Scores Another Breakthrough For KEYTRUDA®

Eli Lilly And Luminex Exclusive: Straight Talk From Career Experts On How To Get Hired

Pfizer's $11 Billion Buyback Dims Prospects Of AstraZeneca PLC Bid

Clarus Ventures Adds And To Cambridge Office

Chemical In Drinking Water Linked To Stillbirth, Boston University Study

Heart Drug May Help Treat ALS, Washington University School of Medicine Study

Gene Link To Seizures In Children After MMR Vaccine, Statens Serum Institut (SSI) Study

Dark Days Are Here For Folks With Seasonal Depression, Study

Gene That Once Aided Survival In The Arctic Found To Have Negative Impact On Health Today, University of Cambridge Study

Herbal Medicines Could Contain Dangerous Levels Of Toxic Mold,

Science Confirms Occasional Weed Use Doesn't Lower Your IQ, University College London Study

Sunshine May Slow Weight Gain And Diabetes Onset, University of Edinburgh Study

Five Prime Therapeutics, Inc. Snags An Expanded Deal Worth $196.3 Million With GlaxoSmithKline

Tug-Of-War Over Revlimid Patent Continues Between Celgene, Natco Pharma Limited

How Regeneron Is Benefiting From Continued Sanofi Investments

Ten Men For Every Woman Present In Biotech Boardrooms: Reports

New AbbVie Head Blasts Canada???s Patent Laws On Drugs

New Actavis CEO Has $70 Billion In Deals To Choose From

Strong Earnings Could Mean Buying Spree For Alexion Pharmaceuticals Inc., Says Analyst

Biogen Idec Slumps After Patient On Top-Selling Drug Dies

Shire Stands To Grab $1.6B From AbbVie In Third Largest Breakup Fee In History

FDA Postpones Its Final Decision On NPS Pharmaceuticals, Inc.'s Natpara

BioSpace???s Favorite FDA Tricks Or Treats

AstraZeneca PLC's Cancer Drug Pipeline Gets Boost From European Green Light

Billionaire Pledges $100 Million To Fight Ebola

Genmab A/S Banks $10 Million Milestone Payment From Janssen Biotech Inc.

QLT Inc. Appoints As Interim CEO

Baxter International, Inc.'s Hemophilia A Drug Obizur Wins FDA Approval

Hikma Pharmaceuticals Falls On FDA Warning For Portugal Plant

Ocera Therapeutics, Inc.???s New HE Drug Could Pull Stock Up Out Of Rut: Cowen

Actavis Takes Axe To Forest Laboratories, Inc. Again; Cuts 100 Jobs In New York

KeraNetics, LLC Quadrupling Manufacturing Space With Plan To Move Into Targacept, Inc.'s Old Haunts

If You???re Over 60, Drink Up: Alcohol Associated With Better Memory, University of Texas Study

Omega 3 Can Help Children With ADD, University of Gothenburg Study

Cash Receipts Account For High BPA Levels In Humans, University of Missouri Study

Finally: A Missing Link Between Vitamin D and Prostate Cancer, University of Colorado Study

High-Fat Meals Could Be More Harmful To Males Than Females, Cedars-Sinai Medical Center Reveals

Top 30 Life Science Startups To Watch In The U.S.

Drugmakers Like GlaxoSmithKline May Need Compensation For Fast-Tracked Ebola Vaccines

Johnson & Johnson To Launch Incubator At Houston???s To Boost Biotechs

SF Wants Pharma To Pay For A Take-Back Program; Who's Next?

Gilead Sciences, Inc. To Create More Than 80 Jobs With $50 Million Expansion

SSF's Sutro Biopharma Forges $1 Billion+ And Option To Buy Pact With Celgene

Celgene Beats The Street Again On Earnings And Analysts Couldn???t Be Happier

Activist Investor Urges Amgen To Break Up

New Role Created At GlaxoSmithKline's Vaccines Unit

Novartis AG's AIN457 Meets Primary Endpoint In Two Late Stage Studies

222


    Read more..